nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—SHMT1—One Carbon Metabolism—ATIC—osteoporosis	0.0749	0.0787	CbGpPWpGaD
Mimosine—SHMT1—Metabolism of folate and pterines—MTHFR—osteoporosis	0.0486	0.051	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—PRDX3—osteoporosis	0.0357	0.0375	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—COL1A2—osteoporosis	0.0275	0.0288	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—PRDX3—osteoporosis	0.0272	0.0285	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NFATC1—osteoporosis	0.0261	0.0274	CbGpPWpGaD
Mimosine—CCL2—Calcitriol—Ergocalciferol—osteoporosis	0.0256	0.54	CbGdCrCtD
Mimosine—CCL2—IL-1 signaling pathway—IRAK3—osteoporosis	0.0255	0.0268	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—BGLAP—osteoporosis	0.0238	0.025	CbGpPWpGaD
Mimosine—CCL2—Calcitriol—Cholecalciferol—osteoporosis	0.0218	0.46	CbGdCrCtD
Mimosine—SHMT1—One Carbon Metabolism—MTHFR—osteoporosis	0.0196	0.0206	CbGpPWpGaD
Mimosine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	0.0195	0.0205	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—GAPDH—osteoporosis	0.0181	0.019	CbGpPWpGaD
Mimosine—CCL2—Unfolded Protein Response (UPR)—TLN1—osteoporosis	0.0179	0.0188	CbGpPWpGaD
Mimosine—SHMT1—Trans-sulfuration and one carbon metabolism—MTHFR—osteoporosis	0.0176	0.0185	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—COL1A2—osteoporosis	0.0165	0.0173	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—NFATC1—osteoporosis	0.0157	0.0165	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—ENO1—osteoporosis	0.0142	0.0149	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—SOD2—osteoporosis	0.0114	0.012	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—SOD2—osteoporosis	0.0112	0.0118	CbGpPWpGaD
Mimosine—CCL2—IL1 and megakaryotyces in obesity—IL1B—osteoporosis	0.0109	0.0114	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—GPX1—osteoporosis	0.0107	0.0112	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.0101	0.0106	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—MTHFR—osteoporosis	0.00987	0.0104	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—SOD2—osteoporosis	0.00929	0.00975	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—TNFRSF11B—osteoporosis	0.00926	0.00972	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—NFATC1—osteoporosis	0.00911	0.00956	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—GPX1—osteoporosis	0.00886	0.0093	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—WNT1—osteoporosis	0.0087	0.00913	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—MTHFR—osteoporosis	0.00818	0.00858	CbGpPWpGaD
Mimosine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.00791	0.00831	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL1B—osteoporosis	0.00771	0.00809	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—SOD2—osteoporosis	0.00738	0.00775	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CALCR—osteoporosis	0.00715	0.00751	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—PTH1R—osteoporosis	0.00715	0.00751	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—GPX1—osteoporosis	0.00704	0.00739	CbGpPWpGaD
Mimosine—SHMT1—Amino acid and derivative metabolism—PSMA2—osteoporosis	0.00701	0.00735	CbGpPWpGaD
Mimosine—SHMT1—Amino acid and derivative metabolism—PSMA5—osteoporosis	0.00701	0.00735	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—ESR1—osteoporosis	0.00693	0.00728	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—IRS1—osteoporosis	0.00687	0.00722	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—MTHFR—osteoporosis	0.0065	0.00682	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IL1B—osteoporosis	0.00596	0.00626	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL1B—osteoporosis	0.00586	0.00615	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—IL1B—osteoporosis	0.00562	0.00589	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—TNF—osteoporosis	0.0056	0.00587	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—CCT2—osteoporosis	0.00527	0.00553	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—TNF—osteoporosis	0.00506	0.00531	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL1B—osteoporosis	0.00485	0.00509	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00481	0.00505	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—LEP—osteoporosis	0.00478	0.00502	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—osteoporosis	0.00452	0.00474	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL6—osteoporosis	0.00452	0.00474	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—TUBA1B—osteoporosis	0.00448	0.00471	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—TNF—osteoporosis	0.00433	0.00454	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TNF—osteoporosis	0.00425	0.00446	CbGpPWpGaD
Mimosine—SHMT1—Disease—SOST—osteoporosis	0.00413	0.00434	CbGpPWpGaD
Mimosine—SHMT1—Disease—PKM—osteoporosis	0.00413	0.00434	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—IL6—osteoporosis	0.00408	0.00428	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—MYC—osteoporosis	0.00395	0.00415	CbGpPWpGaD
Mimosine—SHMT1—Disease—PGLS—osteoporosis	0.00392	0.00411	CbGpPWpGaD
Mimosine—SHMT1—Disease—ANTXR2—osteoporosis	0.00392	0.00411	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IL1B—osteoporosis	0.00386	0.00405	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—PTH—osteoporosis	0.00376	0.00394	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PTH1R—osteoporosis	0.00367	0.00385	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CALCR—osteoporosis	0.00367	0.00385	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CNR2—osteoporosis	0.00366	0.00384	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—MYC—osteoporosis	0.00361	0.00379	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TGFB1—osteoporosis	0.0036	0.00378	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—RPL24—osteoporosis	0.00358	0.00376	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TNF—osteoporosis	0.00352	0.0037	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IL6—osteoporosis	0.00349	0.00367	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PKM—osteoporosis	0.00346	0.00363	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—FDPS—osteoporosis	0.00346	0.00363	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—WNT1—osteoporosis	0.00344	0.00361	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL6—osteoporosis	0.00343	0.0036	CbGpPWpGaD
Mimosine—SHMT1—Disease—GSN—osteoporosis	0.00333	0.0035	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GPD2—osteoporosis	0.00328	0.00344	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PGLS—osteoporosis	0.00328	0.00344	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—TLN1—osteoporosis	0.00315	0.00331	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—PTHLH—osteoporosis	0.00311	0.00327	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL1B—osteoporosis	0.00305	0.0032	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—REN—osteoporosis	0.00303	0.00318	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PNP—osteoporosis	0.003	0.00315	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ATIC—osteoporosis	0.003	0.00315	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MGLL—osteoporosis	0.00292	0.00306	CbGpPWpGaD
Mimosine—SHMT1—Disease—LRP5—osteoporosis	0.0029	0.00304	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL6—osteoporosis	0.00284	0.00298	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—POMC—osteoporosis	0.00281	0.00295	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—TNF—osteoporosis	0.0028	0.00294	CbGpPWpGaD
Mimosine—SHMT1—Disease—LRP6—osteoporosis	0.00277	0.00291	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CALCA—osteoporosis	0.00274	0.00288	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL6—osteoporosis	0.00271	0.00285	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—TNF—osteoporosis	0.0027	0.00283	CbGpPWpGaD
Mimosine—SHMT1—Disease—RPL24—osteoporosis	0.00266	0.00279	CbGpPWpGaD
Mimosine—SHMT1—Disease—LTF—osteoporosis	0.00266	0.00279	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CA2—osteoporosis	0.00255	0.00268	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—OXCT1—osteoporosis	0.00255	0.00268	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MGLL—osteoporosis	0.00249	0.00261	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SOST—osteoporosis	0.0024	0.00252	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MYC—osteoporosis	0.00238	0.00249	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TGFB1—osteoporosis	0.00237	0.00249	CbGpPWpGaD
Mimosine—SHMT1—Disease—ACP5—osteoporosis	0.00231	0.00242	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IL6—osteoporosis	0.00226	0.00237	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TNF—osteoporosis	0.00221	0.00232	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—IL6—osteoporosis	0.00218	0.00229	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CALCR—osteoporosis	0.00217	0.00228	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTH1R—osteoporosis	0.00217	0.00228	CbGpPWpGaD
Mimosine—SHMT1—Disease—TPI1—osteoporosis	0.00215	0.00225	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—IDH2—osteoporosis	0.00211	0.00222	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—MYC—osteoporosis	0.0021	0.0022	CbGpPWpGaD
Mimosine—SHMT1—Disease—P4HB—osteoporosis	0.00202	0.00212	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP27A1—osteoporosis	0.00199	0.00209	CbGpPWpGaD
Mimosine—SHMT1—Disease—GAPDH—osteoporosis	0.00198	0.00208	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ACP5—osteoporosis	0.00193	0.00203	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PTH—osteoporosis	0.00193	0.00202	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—ACE—osteoporosis	0.00189	0.00198	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00188	0.00198	CbGpPWpGaD
Mimosine—SHMT1—Disease—NFATC1—osteoporosis	0.00188	0.00198	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CNR2—osteoporosis	0.00188	0.00197	CbGpPWpGaD
Mimosine—SHMT1—Disease—DKK1—osteoporosis	0.00187	0.00196	CbGpPWpGaD
Mimosine—SHMT1—Disease—WNT1—osteoporosis	0.0018	0.00189	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TPI1—osteoporosis	0.0018	0.00189	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL6—osteoporosis	0.00179	0.00187	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—WNT1—osteoporosis	0.00177	0.00185	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGA—osteoporosis	0.00175	0.00184	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MGLL—osteoporosis	0.00172	0.00181	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—P4HB—osteoporosis	0.00169	0.00177	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LRP5—osteoporosis	0.00168	0.00176	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GAPDH—osteoporosis	0.00166	0.00174	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—RAP1A—osteoporosis	0.00162	0.0017	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LRP6—osteoporosis	0.00161	0.00169	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PTHLH—osteoporosis	0.0016	0.00168	CbGpPWpGaD
Mimosine—SHMT1—Disease—ENO1—osteoporosis	0.00156	0.00164	CbGpPWpGaD
Mimosine—SHMT1—Disease—PSMA2—osteoporosis	0.00154	0.00161	CbGpPWpGaD
Mimosine—SHMT1—Disease—PSMA5—osteoporosis	0.00154	0.00161	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—POMC—osteoporosis	0.00143	0.0015	CbGpPWpGaD
Mimosine—SHMT1—Disease—CALCA—osteoporosis	0.00143	0.0015	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CALCA—osteoporosis	0.00141	0.00148	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TLN1—osteoporosis	0.00136	0.00142	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ENO1—osteoporosis	0.00131	0.00137	CbGpPWpGaD
Mimosine—SHMT1—Disease—KL—osteoporosis	0.0013	0.00136	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PSMA5—osteoporosis	0.00129	0.00135	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PSMA2—osteoporosis	0.00129	0.00135	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—LEP—osteoporosis	0.00117	0.00123	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—P4HB—osteoporosis	0.00117	0.00123	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTH—osteoporosis	0.00114	0.0012	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—RAP1A—osteoporosis	0.00112	0.00117	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CNR2—osteoporosis	0.00111	0.00116	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NFATC1—osteoporosis	0.00109	0.00115	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DKK1—osteoporosis	0.00108	0.00114	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP19A1—osteoporosis	0.00104	0.0011	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—WNT1—osteoporosis	0.00104	0.0011	CbGpPWpGaD
Mimosine—SHMT1—Disease—ADCY5—osteoporosis	0.00102	0.00107	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGA—osteoporosis	0.00101	0.00107	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—POMC—osteoporosis	0.00101	0.00106	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ADCY5—osteoporosis	0.001	0.00105	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—IGF1—osteoporosis	0.00097	0.00102	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—BMP2—osteoporosis	0.000944	0.00099	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTHLH—osteoporosis	0.000944	0.00099	CbGpPWpGaD
Mimosine—SHMT1—Disease—MTHFR—osteoporosis	0.000937	0.000983	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGB—osteoporosis	0.000923	0.000969	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PSMA2—osteoporosis	0.000891	0.000936	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PSMA5—osteoporosis	0.000891	0.000936	CbGpPWpGaD
Mimosine—SHMT1—Disease—IRS2—osteoporosis	0.000891	0.000935	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ADCY5—osteoporosis	0.000853	0.000895	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GPX1—osteoporosis	0.00085	0.000892	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CALCA—osteoporosis	0.000831	0.000872	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MTHFR—osteoporosis	0.000784	0.000823	CbGpPWpGaD
Mimosine—SHMT1—Disease—IRS1—osteoporosis	0.000778	0.000816	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KL—osteoporosis	0.000754	0.000792	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—POMC—osteoporosis	0.000736	0.000772	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL6R—osteoporosis	0.000731	0.000767	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL6R—osteoporosis	0.000718	0.000753	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—POMC—osteoporosis	0.000627	0.000658	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ADCY5—osteoporosis	0.000591	0.00062	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SPP1—osteoporosis	0.000572	0.0006	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IRS2—osteoporosis	0.000517	0.000543	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LEP—osteoporosis	0.000506	0.000531	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ESR1—osteoporosis	0.000483	0.000507	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IRS1—osteoporosis	0.000451	0.000474	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—POMC—osteoporosis	0.000435	0.000456	CbGpPWpGaD
Mimosine—SHMT1—Disease—MYC—osteoporosis	0.000433	0.000455	CbGpPWpGaD
Mimosine—SHMT1—Disease—TGFB1—osteoporosis	0.000432	0.000453	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL6R—osteoporosis	0.000424	0.000445	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IGF1—osteoporosis	0.000418	0.000439	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL6—osteoporosis	0.000325	0.000342	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL6—osteoporosis	0.00032	0.000336	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MYC—osteoporosis	0.000251	0.000264	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TGFB1—osteoporosis	0.000251	0.000263	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL6—osteoporosis	0.000189	0.000198	CbGpPWpGaD
